期刊文献+

非小细胞肺癌骨转移患者无骨相关事件生存期与生存期影响因素的对比分析 被引量:2

Comparative analysis of the influence factors on SRE-free survival and over-all survival in non-small cell lung cancer patients with bone metastases
原文传递
导出
摘要 目的探讨非小细胞肺癌骨转移患者的各临床病理特征对无骨相关事件生存期与生存期的影响。方法选取哈尔滨医科大学附属肿瘤医院2007年1月至2012年1月间211例非小细胞肺癌骨转移患者,对其临床病例资料进行单因素与多因素分析,再将是否双磷酸盐治疗这一因素按首诊临床分期进行分层处理。结果首诊时临床分期、是否有骨相关事件是影响生存期的独立风险因素(P <0. 05),首诊时临床分期、是否有骨痛、原发灶是否放疗、是否化疗是影响无骨相关事件生存期的独立风险因素(P <0. 05)。Ⅰ、Ⅱ、Ⅲ期的患者双磷酸盐治疗组的无骨相关事件生存期明显长于无双磷酸盐治疗组,而Ⅳ期的患者双磷酸盐治疗组与无双磷酸盐治疗组的无骨相关事件生存期无明显差别。结论明确非小细胞肺癌骨转移患者无骨相关事件生存期与生存期的影响因素有助于提高其生活质量,并延长生存期。 Objective To investigate the impact of the clinical and pathological prognostic fac- tors on SRE-free survival and overall survival in non-small cell lung cancer patients with bone metastases. Methods Two hundred and eleven-one non-small cell lung cancer patients with bone metastases treated in the Affiliated Cancer Hospital of Harbin Medical University between January 2003 and January 2010 were selected for univariate and multivariate analysis based on their clinical data, and bisphosphonate therapy was evaluated based on the first diagnosis of clinical stage. Results Clinical stage of the first diagnosed, with or without SRE were inde- pendent factors affecting the prognosis of overall survival ( P 〈 0.05 ) , clinical stage of the first diagnosed, with or without pain, with or without primary tumor radiotherapy, and with or with- out chemotherapy were independent factors affecting the prognosis of SRE-free survival (P 〈 0.05 ). Survival period of I / II /III stage group with bisphosphonate therapy was significantly longer than the without bisphosphonate therapy group, and there was no significant difference in IV stage patients between with bisphosphonates treated and no bisphosphate treated in SRE-free survival. Conelusion Clearing the influence factors on SRE-free survival and overall survival in non-small cell lung cancer patients with bone metastases can improve their quality of life and prolong overall survival.
作者 刘东辉 王旭瑶 吴瑾 LIU Dong-hui;WANG Xu-yao;WU Jin(Department of Internal Medicine,The Affiliated Cancer Hospital of Harbin Medical Universi-ty,Harbin 150081,China;Hematologic oncology Department,Second Hospital of Harbin,Harbin 150056,China;Department of Pharmacology,Harbin Medical University,Harbin 150081,China)
出处 《哈尔滨医科大学学报》 CAS 2018年第2期136-141,共6页 Journal of Harbin Medical University
关键词 非小细胞肺癌 骨转移 无骨相关事件生存期 生存期 单因素分析 多因素分析 non small cell lung cancer bone metastases SRE-free survival overall survival univariate analysis multivariate analysis
  • 相关文献

参考文献2

二级参考文献25

  • 1张青,胡云,张莉,苏红媛,叶恒光.核素骨显像在肺癌骨转移诊断中的应用[J].重庆医学,2005,34(8):1136-1136. 被引量:9
  • 2黄河清,章五一,庞倩.综合疗法治疗非小细胞肺癌骨转移120例临床分析[J].广东医学院学报,2005,23(5):582-583. 被引量:3
  • 3赵新华,张宜生,张华,李庆,阳秀芝,蒋显勇,张忠山,谢菊英.博宁治疗骨转移癌36例疗效观察[J].中国肿瘤临床与康复,2006,13(1):91-92. 被引量:4
  • 4吴涛,崔东海,王晓芳.非小细胞肺癌骨转移疗效对比研究[J].医药论坛杂志,2006,27(17):45-46. 被引量:4
  • 5Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity[J]. Clin Cancer Res, 2006, 12(20) :6243. 被引量:1
  • 6Sugiura H,Yamada K,Sugiura T,et al. Predictors of survival in patients with bone metastasis of lung cancer[J]. Clin Orthop Relat Res,2008,466(3) : 729. 被引量:1
  • 7Gebba V, Galetta D, Riceardi F, et al. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomg MC in stage ⅢB-Ⅳ non-small cell lung carcin oma:a prospective randomized study[J]. Lung cancer,2002,37(2): 179. 被引量:1
  • 8Bobilev D, Lavrenkov K, Cohen Y, et al. Vinorelbine plus cisplatin as first-line combi-nation chemotherapy for ad vaneed non-small cell lung cancer Retrosp-ective analysis [J]. Oncology forum, 2004,7 ( 1 ) : 3. 被引量:1
  • 9Mori K,Kamiyama R,Kondo T,et al. Phase Ⅱ study of the combination of vinorelbine and cisplatin in advanced non-small cell lung cancer[J]. Cancer chemotherapy pharmacol,2004,53(2) :129. 被引量:1
  • 10Manus MP, Hicks RJ, Matthews JP,et al. Metabolic(fdgpet) response after radical- radiotherapy for non-small cell lung cancer correlates with patterns of failor[J]. Int J Lung Cancer,2005,49(1) :95. 被引量:1

共引文献27

同被引文献25

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部